GSK Plc (GLAXF)
GSK Market Cap : 108.74B for April 23, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Silence Therapeutics Plc | 334.42M |
| Adaptimmune Therapeutics Plc | 2.650M |
| Biodexa Pharmaceuticals Plc | 2.217M |
| Oxford Biomedica Plc | 1.028B |
| NuCana Plc | 8.948M |
Market Cap Related Metrics
| PE Ratio | 14.86 |
| PS Ratio | 2.593 |
| PEG Ratio | 0.113 |
| Price to Book Value | 4.937 |
| Price to Free Cash Flow | 19.47 |
| Price | 27.21 |
| Earnings Yield | 6.73% |
| PEGY Ratio | 0.1102 |
| Operating PE Ratio | 11.49 |
| Normalized PE Ratio | 13.76 |